Christine J. Chung

Christine J. Chung

Auto-generated profile, based on publicly available information

Christine J. Chung

University of Washington Medical Center, Seattle, Washington, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
GCGregory J. Condos
Gregory J. Condos
DEDavid Elison
David Elison
LVLogan L. Vincent
Logan L. Vincent
RHRafael Harari
Rafael Harari
CSCristina Sanina
Cristina Sanina
JMJames M. McCabe
James M. McCabe
BACKGROUND: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited. METHODS: This study describes our initial experience with a novel procedure to address large mitral annuli when no surgical or trial-based transcatheter mitral valve replacement device is available. The rationale was to shorten the intercommissural distance using commissural mitral transcatheter edge-to-edge repair (TEER) followed by valve-in-mitral annular calcification transcatheter mitral valve replacement with a balloon-expandable aortic valve platform. Patients with long intercommissural distances and large mitral annulus areas were selected based on a high perceived risk of transcatheter valve embolization. Patients underwent mitral TEER with MitraClip in a commissural position, followed immediately by transseptal transcatheter mitral valve replacement with a 29 mm SAPIEN 3 valve. RESULTS: Thirteen patients were included. Median intercommissural distance and annular area were 39.1 mm and 930 mm 2 , respectively. Commissural mitral TEER was successful in all patients with no instances of single leaflet detachment. In 10 of 13 instances, an NTW device size was used. In 12 of 13 patients, valve implantation was successful, including 1 case that required a second valve for atrial positioning of the first valve. In 1 case, frank valve embolization into the left atrium occurred. Among the 12 successful cases, paravalvular leak was 1+ or less, and there were no instances of paravalvular leak adjacent to the TEER device. CONCLUSIONS: In patients with large annuli and sufficient annular calcium, a hybrid mitral TEER and valve replacement with the SAPIEN platform can be successfully used to facilitate transcatheter mitral valve replacement.

9 March 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
CCChristine J Chung
Christine J Chung
COCatherine M Otto
Catherine M Otto
Christine J Chung, MD, Catherine M Otto, MD; Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation, European Hea

14 August 2024 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
DEDavid Elison
David Elison
BDBarbara A. Danek
Barbara A. Danek
BJBryce V. Johnson
Bryce V. Johnson
CCChristine J. Chung
Christine J. Chung
SOShakirat Oyetunji
Shakirat Oyetunji
JMJames M. McCabe
James M. McCabe
We aimed to develop a transcatheter aortic valve replacement (TAVR) sizing algorithm and implantation method to facilitate safe and effective TAVR without contrast use in patients with severe chronic kidney disease (CKD) who do not yet require renal replacement therapy. Patients with CKD are a challenging patient subset to treat using standard TAVR care pathways which most usually require the use of iodinated contrast media both during gated computed tomography (CT) angiography sizing, and valve deployment. Iodinated contrast exposure may worsen kidney function in a dose-dependent fashion, and may result in a need for renal replacement therapy. Therefore, a method to eliminate, or greatly lessen, contrast exposure during TAVR is highly desirable. One hundred sixty patients who underwent standard CT angiography and TAVR implantation were used to develop (100 patients) and validate (60 patients) an algorithm to predict balloon-expandable valve size using measurements available from noncontrast CT. Model accuracy was measured using Pearson correlation between algorithm-predicted valve size and actual size used based on annular area. As proof of concept, we then report a case series of 35 consecutive patients who underwent TAVR evaluation and implantation with moderate sedation and no contrast between May 2021 and April 2024. The valve sizing algorithm incorporates sinus and sinotubular junction diameters, both available from a reformatted noncontrast, cardiac-gated CT. The algorithm demonstrated a strong correlation with the actual valve size used (development cohort R = 0.81, validation cohort R = 0.76). Thirty-five patients underwent “no-contrast TAVR” with noncontrast CT for valve sizing. Forty-eight percent were urgent inpatient TAVR. Technical procedural success, as defined by the VARC3 criteria, was 100%, with no patient deaths during the index procedure. Three patients had a mild paravalvular leak. No valve embolization or need for a second valve occurred. Four patients required a pacemaker. We present a novel algorithm for TAVR evaluation and implantation without the use of iodinated contrast media in a high-risk patient subset with CKD.

1 October 2024 in Interventional Cardiology Clinics
Verified
Journal Article
Closed access
ALAngela M. Lowenstern
Angela M. Lowenstern
NMNidhi Madan
Nidhi Madan
CCChristine J. Chung
Christine J. Chung

23 September 2025 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
BDBarbara A. Danek
Barbara A. Danek
SDScott DeRoo
Scott DeRoo
DEDavid Elison
David Elison
CCChristine J. Chung
Christine J. Chung
JMJames M. McCabe
James M. McCabe

18 March 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
DEDavid Elison
David Elison
MCMorgan Casper
Morgan Casper
GCGregory Condos
Gregory Condos
OMOscar Maitas
Oscar Maitas
CCChristine J. Chung
Christine J. Chung
JMJames M. McCabe
James M. McCabe